ClinicalTrials.Veeva

Menu

Compuflo Instrument for Thoracic ES Identification

University of Miami logo

University of Miami

Status

Terminated

Conditions

Thoracic
Anesthesia

Treatments

Device: Compuflo Epidural Instrument

Study type

Interventional

Funder types

Other

Identifiers

NCT03376256
20170665

Details and patient eligibility

About

The purpose of this pilot study is to evaluate whether the Compuflo Epidural Instrument injection pump technology, which is FDA approved for lumbar epidural anesthesia, is also capable of identifying the thoracic epidural space through measurement of pressure levels. While this device is approved by the FDA for use in the procedure of the lumbar epidural, it is not used to perform the epidural procedure but rather to measure the epidural pressure. This study will likewise measure the epidural pressure.

Enrollment

2 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 to 80 years inclusive
  • BMI 18.5 to 40 inclusive
  • Scheduled for thoracic epidural anesthesia

Exclusion criteria

  • Patients younger than 18 years or older than 80 years of age
  • Patients with BMI less than 18.5 or greater than 40
  • Contraindication to thoracic epidural anesthesia
  • Allergy or hypersensitivity to local anesthetics
  • Patients with preexisting nerve damage
  • Patients unable to provide written informed consent
  • Individuals of vulnerable populations: children, pregnant women, prisoners

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

2 participants in 2 patient groups

Phase A - Thoracic ES with LOR
Experimental group
Description:
Patients will receive thoracic epidural anesthesia. The thoracic epidural needle will be introduced until loss of resistance (LOR) is perceived to identify the thoracic epidural space (ES). The Compuflo Epidural Instrument will be used to record pressure readings. The thoracic epidural procedure will then continue per standard of care.
Treatment:
Device: Compuflo Epidural Instrument
Phase B - Thoracic ES with Compuflo
Experimental group
Description:
Patients will receive thoracic epidural anesthesia. The thoracic epidural needle will be introduced until the Compuflo Epidural Instrument indicates that pressure has decreased. The loss of resistance technique will then be used to identify the thoracic epidural space. The thoracic epidural procedure will then continue per standard of care.
Treatment:
Device: Compuflo Epidural Instrument

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems